CNO Financial Group, Inc.
CNO
$40.05
$1.263.25%
| Weiss Ratings | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | A- | |||
| Rating Factors | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.05 | |||
| Price History | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.30% | |||
| 30-Day Total Return | 0.18% | |||
| 60-Day Total Return | 5.73% | |||
| 90-Day Total Return | 16.92% | |||
| Year to Date Total Return | 8.27% | |||
| 1-Year Total Return | 54.45% | |||
| 2-Year Total Return | 87.64% | |||
| 3-Year Total Return | 81.73% | |||
| 5-Year Total Return | 332.55% | |||
| 52-Week High % Change | -8.54% | |||
| 52-Week Low % Change | 55.66% | |||
| Price | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $42.41 | |||
| 52-Week Low Price | $24.92 | |||
| 52-Week Low Price (Date) | Apr 11, 2024 | |||
| 52-Week High Price (Date) | Mar 03, 2025 | |||
| Valuation | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.91B | |||
| Enterprise Value | 6.87B | |||
| Price/Earnings (TTM) | 10.37 | |||
| Earnings Per Share (TTM) | 3.74 | |||
| Earnings Per Share Growth | 55.55% | |||
| Price/Earnings To Growth | 0.19 | |||
| Price/Sales (TTM) | 0.92 | |||
| Price/Book (Q) | 1.58 | |||
| Enterprise Value/Revenue (TTM) | 1.54 | |||
| Price | $40.05 | |||
| Enterprise Value/EBITDA (TTM) | 6.45 | |||
| Enterprise Value/EBIT | 8.90 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 105.23M | |||
| Dividend Yield | 1.65% | |||
| Div. Per Share (Most Recent) | $0.16 | |||
| Dividend Per Share (TTM) | $0.64 | |||
| Payout Ratio (TTM) | 16.76% | |||
| Dividend Per Share (Most Recent) | $0.16 | |||
| Company Info | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 317 817 6100 | |||
| Address | 11299 Illinois Street Carmel, IN 46032 | |||
| Website | www.cnoinc.com | |||
| Country | United States | |||
| Year Founded | 1979 | |||
| Profitability | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 17.36% | |||
| Profit Margin | 9.07% | |||
| Management Effectiveness | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.33% | |||
| Return on Equity | 17.14% | |||
| Income Statement | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.31B | |||
| Total Revenue (TTM) | 4.45B | |||
| Revenue Per Share | $42.28 | |||
| Gross Profit (TTM) | 1.83B | |||
| EBITDA (TTM) | 1.07B | |||
| EBIT (TTM) | 772.70M | |||
| Net Income (TTM) | 404.00M | |||
| Net Income Avl. to Common (TTM) | 404.00M | |||
| Total Revenue Growth (Q YOY) | -6.26% | |||
| Earnings Growth (Q YOY) | 357.58% | |||
| EPS Diluted (TTM) | 3.74 | |||
| EPS Diluted Growth (Q YOY) | 402.19% | |||
| Balance Sheet | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.96B | |||
| Cash Per Share (Q) | $18.63 | |||
| Total Current Assets (Q) | 6.75B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.50B | |||
| Current Ratio (Q) | 3.427 | |||
| Book Value Per Share (Q) | $24.59 | |||
| Total Assets (Q) | 37.85B | |||
| Total Current Liabilities (Q) | 1.97B | |||
| Total Debt (Q) | 4.62B | |||
| Total Liabilities (Q) | 35.35B | |||
| Total Common Equity (Q) | 2.50B | |||
| Cash Flow | CNO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.49B | |||
| Cash from Financing (TTM) | 1.97B | |||
| Net Change in Cash (TTM) | 1.11B | |||
| Levered Free Cash Flow (TTM) | 537.04M | |||
| Cash from Operations (TTM) | 627.70M | |||
